MLN1117
C032-6001 (MLN1117-1003)
Phase 1 small_molecule terminated
Quick answer
MLN1117 for Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated